Skip to main content
. Author manuscript; available in PMC: 2021 Oct 20.
Published in final edited form as: J Behav Med. 2021 May 11;44(5):630–640. doi: 10.1007/s10865-021-00223-z

Table 2.

Change in outcomes over 12 months for high and low profiles

Outcome (standard error) Baseline 3 months 12 months BL-3 months BL-12 months
z value p value Cohen’s d z value p value Cohen’s d
PCS
Low P only; n = 89 40.65 (1.02) 41.45 (1.04) 39.29 (1.06) 0.76 0.447 0.08 − 1.28 0.199 0.14
Low P + P; n = 81 42.74 (10.7) 43.06 (1.09) 41.63 (1.10) 0.29 0.768 0.01 − 1.01 0.312 0.11
High p only; n = 62 5.060 (0.43) 54.88 (0.45) 53.13 (0.45) 2.82 0.005 0.30 − 1.03 0.301 0.11
High P + P; n = 69 54.75 (0.41) 54.89 (0.42) 54.26 (0.42) 0.33 0.743 0.04 − 1.15 0.250 0.13
MCS
Low P only; n = 64 42.49 (1.30) 44.12 (1.44) 45.21 (1.71) 0.99 0.324 0.12 1.60 0.110 0.20
Low P + P; n = 82 44.31 (1.14) 47.58 (1.10) 50.23 (1.29) 2.27 0.023 0.25 4.08 < 0.001 0.45
High p only; n = 87 57.25 (0.43) 58.32 (0.44) 59.06 (0.44) 2.22 0.026 0.28 3.74 < 0.001 0.40
High P + P; n = 68 56.72 (0.49) 59.25 (0.49) 58.63 (0.50) 4.67 < 0.001 0.52 3.50 < 0.001 0.42
Depression
Low P only; n = 58 1.17 (0.15) 0.56 (0.16) 0.53 (0.16) 4.00 < 0.001 0.52 4.12 < 0.001 0.54
Low P + P; n = 84 1.60 (0.13) 0.83 (0.13) 1.36 (0.13) 6.18 < 0.001 0.67 − 1.94 0.052 0.21
High p only; n = 93 6.36 (0.46) 5.81 (0.47) 5.57 (0.48) − 1.12 0.263 0.12 − 1.56 0.118 0.16
High P + P; n = 66 6.99 (0.55) 5.48 (0.56) 5.04 (0.57) 2.59 0.010 0.32 3.27 0.001 0.36
Anxiety
Low P only; n = 43 22.61 (0.50) 21.52 (0.52) 21.57 (0.52) − 1.64 0.102 0.25 − 1.56 0.119 0.24
Low P + P; n = 50 25.88 (0.46) 20.67 (0.47) 20.37 (0.48) 8.59 < 0.001 1.21 8.98 < 0.001 1.27
High p only; n = 108 37.59 (1.02) 34.27 (1.03) 33.67 (1.06) 3.02 0.003 0.29 3.48 0.001 0.33
High P + P; n = 100 36.30 (1.06) 33.89 (1.06) 33.08 (1.09) 2.38 0.017 0.24 2.79 0.005 0.28
Caregiver burden
Low P only; n = 108 1.60 (0.02) 1.41 (0.02) 1.41 (0.02) 10.76 < 0.001 1.04 10.17 < 0.001 0.98
Low P + P; n = 96 1.49 (0.02) 1.30 (0.02) 1.26 (0.02) 9.41 < 0.001 0.97 11.52 < 0.001 1.18
High p only; n = 43 2.12 (0.07) 2.12 (0.08) 2.10 (0.08) − 0.05 0.959 0.01 − 0.28 0.780 0.04
High P + P; n = 54 2.08 (0.07) 1.80 (0.07) 1.79 (0.07) 4.38 < 0.001 0.59 4.34 < 0.001 0.58
Self-efficacy
Low P only; n = 94 7.45 (0.15) 7.84 (0.15) 7.78 (0.15) 2.64 0.008 0.27 2.18 0.029 0.22
Low P + P; n = 78 7.07 (0.16) 8.10 (0.16) 8.24 (0.17) 6.40 < 0.001 0.72 7.12 < 0.001 0.81
High p only; n = 57 9.14 (0.06) 9.71 (0.06) 9.81 (0.07) 7.02 < 0.001 0.93 8.17 < 0.001 1.18
High P + P; n = 72 9.07 (0.06) 9.71 (0.06) 9.71 (0.06) 8.95 < 0.001 1.05 8.95 < 0.001 1.05

Outcome values for high and low responders at baseline (BL), 3, and 12 months. The comparison of longitudinal outcomes from baseline to 3 months and from baseline to 12 months are simple contrasts from repeated measures mixed models. Differences between the high and low subgroups within the P + P and P-only for all outcomes are significantly different at a p value < 0.001. Bolded values indicate baseline and follow-up values are significantly different at a p value < 0.05